LineaGen, Inc. is a content-based biomarker discovery company focused on the commercialization of novel, patentable diagnostic tests that will lead to more personalized healthcare regimens for human health and disease conditions. One of LineaGen’s core competitive advantages is its access to an unmatched discovery research platform that has been used to identify in Utah more disease causing genes than in any other single place world-wide. LineaGen’s goal is to develop a diversified portfolio of novel biomarkers for the development of new diagnostic tests. LineaGen’s complete website is currently under construction and will be published in January 2008.